A phase-II study evaluatin safety and efficacy with weekly paclitaxel and carboplatin as a primary treatment for patients with advanced epithelial ovarian cancer (EOC)

Tamar Safra,R. Bernstein Molho,Dan Grisaru,S. Spigel,Ravit Geva,Dianna Matcejevsky,Moshe Inbar,J. Menzcer,Tally Levy

A phase-II study evaluatin safety and efficacy with weekly paclitaxel and carboplatin as a primary treatment for patients with advanced epithelial ovarian cancer (EOC)

2006

Tamar Safra
R. Bernstein Molho
Dan Grisaru
S. Spigel
Ravit Geva
Dianna Matcejevsky
Moshe Inbar
J. Menzcer
Tally Levy

5077 Background: The standard chemotherapy for epithelial ovarian cancer (EOC) is carboplatin and paclitaxel every 3 weeks together with debulking surgery. This phase II trial was designed to deter...

Keywords:

Carboplatin
Ovarian cancer
Cancer research
Paclitaxel
Phases of clinical research
Medicine
Pathology
epithelial ovarian cancer
Oncology
weekly paclitaxel
primary treatment
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations